Antiviraler Polypeptidmembranfusionsinhibitor sowie Herstellungsverfahren und Anwendung davon
EP4792821
19. August 2026
Anmelder: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. 🇨🇳
Details
- Veröffentlichungs-Nr.
- EP4792821
- Anmeldetag
- 17. Dezember 2025
- Veröffentlichung
- 19. August 2026
- Rechtsraum
- EP
Abstract
The present disclosure relates to a polypeptide membrane fusion inhibitor against Paramyxoviridae and/or Pneumoviridae viruses, and a preparation method and application thereof. Provided in the present disclosure are a compound, a pharmaceutically acceptable salt or derivative thereof, a pharmaceutical composition and formulation product containing same, and applications thereof for preparation of drugs for preventing and/or treating diseases caused by Paramyxoviridae and/or Pneumoviridae viruses.
Anmelder
- Firma
- Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- Land
- 🇨🇳 China
Vertreten von
-
Novagraaf Technologies
Novagraaf Technologies · Asnières-sur-Seine